The Washington Post explores the evolving peptide landscape, highlighting the challenges and opportunities facing manufacturers, providers, and policymakers alike. As regulatory discussions continue, collaboration between industry leaders, scientific experts, and organizations dedicated to best practices will help shape a stronger and more sustainable future for peptide medicine.
Read the Full Article